What do Eltrombopag/Eltrombopag ethanolamine tablets do?

Eltrombopag/Eltrombopag has a variety of indications and is used to treat some conditions:

1. Treatment of thrombocytopenia (ITP) in patients with persistent or chronic immune thrombocytopenia: Eltrombopag/Eltrombopag is indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have an inadequate response to corticosteroids, immune globulin, or splenectomy.

Eltrombopag should be used only in patients with ITP whose degree of thrombocytopenia and clinical conditions increase the risk of bleeding.

2. Treatment of thrombocytopenia in patients with hepatitis C infection: Eltrombopag is used to treat thrombocytopenia in patients with chronic hepatitis C infection in order to initiate and maintain interferon-based therapy.

Eltrombopag should be used only in patients with chronic hepatitis C who have a degree of thrombocytopenia that prevents initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

3. Treatment of severe aplastic anemia (AA): Eltrombopag is suitable for use in combination with standard immunosuppressive therapy (IST) as the first-line treatment for adults and children with severe aplastic anemia aged 2 years and above; it is also used to treat patients with severe aplastic anemia who have insufficient response to immunosuppressive therapy.

It is understood that eltrombopag is not suitable for the treatment of patients with myelodysplastic syndrome (MDS); the safety and efficacy of eltrombopag in combination with interferon-free direct-acting antiviral drugs for the treatment of chronic hepatitis C infection have not been established. Eltrombopag is a prescription drug. If patients need to use this drug for treatment, they must do so under the guidance of a doctor.